爱博医疗: 688050爱博医疗 股东减持股份计划公告

Core Viewpoint - The major shareholder of Aibo Medical, Bai Ying, plans to reduce her stake by up to 3,862,762 shares, representing no more than 2% of the company's total share capital, through block trading from June 25, 2025, to September 24, 2025, due to personal funding needs [1][2]. Shareholder Information - As of the announcement date, Bai Ying holds 9,562,746 shares, accounting for 7.85% of Aibo Medical's total share capital [1]. - Bai Ying's shares were acquired before the IPO and through capital reserve conversion [1]. Reduction Plan Details - The planned reduction will occur within three months following a 15 trading day period after the announcement [1]. - The reduction price will be determined by the market price at the time of the sale, and adjustments will be made if there are any corporate actions affecting share capital during the reduction period [1]. Shareholder's Previous Reduction Activity - In the past 12 months, Bai Ying reduced her holdings by 1,100,000 shares, which is 0.58% of the total share capital, at a price range of 87.58 yuan per share [1]. Commitment and Compliance - Bai Ying and her associated parties have made commitments regarding the holding period and conditions for any future reductions, ensuring compliance with relevant regulations [2][3]. - The company confirms that the planned reduction aligns with previously disclosed commitments and does not violate any regulations regarding share reduction [3].